Coronary heart disease (CHD) remains the most significant cause of death and morbidity worldwide, yet 85% is preventable. Atherosclerosis with plaque formation is a slow process that starts early in life, and at age 13-19 years about 17% of the population in the U.S. have CHD. This number grows each decade, and around the age of 50, approximately 85% of the population have CHD. By addressing plaque formation with a revolutionary treatment protocol, improved outcomes are highly achievable. This presentation describes the pathophysiology involved in coronary artery plaque formation, including the types of plaque, their assessment, and their clinical significance.

Calcification of coronary plaques is widespread, and the extent, pattern, and location of that calcification has prognostic implications. As part of that discussion, an overview of types of plaque assessment provides hands-on tools for when and with whom testing is indicated. The next critical topic to inform wellness plans is plaque erosion. By detailing how and when plaque erosion occurs, the cause of most thrombosis can be proactively treated. A range of immediately relevant wellness tools, including dietary supplements and medications that will reduce plaque size and stabilize “soft” plaque are discussed in detail. 

Since men and women with CHD and atherosclerotic changes tend to differ in their presenting symptoms, diagnosis, and treatment as well as overall prognosis, the specific risk factors and presenting symptoms for women are highlighted. The most important and the most modifiable CHD risk factors are identified and treatments to address these are described. Radiology imaging, laboratory testing that includes advanced lipid testing, genetic markers, and 24-hour blood pressure monitoring are discussed.  

The revolutionary program developed by the speaker will then be introduced. This comprehensive protocol for addressing plaque regression includes medications, dietary supplements and lifestyle modifications. Three cases of individuals on that protocol will be reviewed to explore how it worked in practice and provide clinical viewpoints into actual results.

Session Learning Objectives:

1.) Understand the pathophysiology of coronary artery calcium and plaque formation.

2.) Evaluate and apply diagnostic testing for coronary heart disease.

3.) Understand and apply  nutrition, nutritional supplements and pharmacology to prevent and treat coronary heart disease.